2003 ARS Immunology Research Workshop
... and secondary hosts. Although considerable amounts of species-specific data have been generated by individual investigators working with zoonotic agents in the animal and human fields, further work is needed to clarify and identify both species-specific and shared protective and/or pathogenic mechan ...
... and secondary hosts. Although considerable amounts of species-specific data have been generated by individual investigators working with zoonotic agents in the animal and human fields, further work is needed to clarify and identify both species-specific and shared protective and/or pathogenic mechan ...
Pigs immunized with Chinese highly pathogenic PRRS virus
... (GenBank ID: EF112445.1), one of the earliest HP-PRRSV strains, was isolated in 2006 and shares 91% homology with the genome of VR-2332 (GenBank ID: AY150564.1). However, during the prevalence of HP-PRRSV from 2006 to 2009, commercial PRRSV vaccines based off the VR-2332 strain failed to protect pig ...
... (GenBank ID: EF112445.1), one of the earliest HP-PRRSV strains, was isolated in 2006 and shares 91% homology with the genome of VR-2332 (GenBank ID: AY150564.1). However, during the prevalence of HP-PRRSV from 2006 to 2009, commercial PRRSV vaccines based off the VR-2332 strain failed to protect pig ...
HUMAN PAPILLOMAVIRUS, VACCINES AND PROTECTION FROM
... though to a lesser extent, have been reported (18). HPV’s ability to establish and develop an infection depends on the reproductive capacity of the host cell. There is no nucleus in cells in the upper layer of normal cervical epithelium. There are continuously dividing cells in the suprabasal layer; ...
... though to a lesser extent, have been reported (18). HPV’s ability to establish and develop an infection depends on the reproductive capacity of the host cell. There is no nucleus in cells in the upper layer of normal cervical epithelium. There are continuously dividing cells in the suprabasal layer; ...
Form for annual reconfirmation
... If domestic ruminants are introduced in the free zone, are they introduced in accordance with requirements at least as strict as those in Chapter 14.7.? 6. If semen, oocytes and embryos are introduced in the free zone, are they introduced in accordance with requirements at least as strict as those i ...
... If domestic ruminants are introduced in the free zone, are they introduced in accordance with requirements at least as strict as those in Chapter 14.7.? 6. If semen, oocytes and embryos are introduced in the free zone, are they introduced in accordance with requirements at least as strict as those i ...
Modeling Population Immunity to Support Efforts to End the
... For polioviruses, the nature of waning remains relatively poorly characterized, although once infected with a LPV (i.e., WPV, OPV, cVDPV, or OPVrelated poliovirus) or effectively vaccinated, it appears that individuals benefit from lifelong protection from homotypic disease (i.e., paralytic polio). ...
... For polioviruses, the nature of waning remains relatively poorly characterized, although once infected with a LPV (i.e., WPV, OPV, cVDPV, or OPVrelated poliovirus) or effectively vaccinated, it appears that individuals benefit from lifelong protection from homotypic disease (i.e., paralytic polio). ...
1 - Jennifer Horne
... period of the vaccine viruses given. Many of the symptoms described were listed in the vaccine manufacturers' own product sheets. The parents reported that their children had suffered serious consequences after the initial symptoms and had not recovered to the health point they had had before the va ...
... period of the vaccine viruses given. Many of the symptoms described were listed in the vaccine manufacturers' own product sheets. The parents reported that their children had suffered serious consequences after the initial symptoms and had not recovered to the health point they had had before the va ...
HyperHEP B® S/D
... final container for 21-28 days at 20-27°C. INDICATIONS AND CLINICAL USE The Canadian Immunization Guide recommends that hepatitis B prevention should include programs for active immunization of children, pre-exposure vaccination of high risk groups, and post-exposure passive immunization for those e ...
... final container for 21-28 days at 20-27°C. INDICATIONS AND CLINICAL USE The Canadian Immunization Guide recommends that hepatitis B prevention should include programs for active immunization of children, pre-exposure vaccination of high risk groups, and post-exposure passive immunization for those e ...
Hepatitis A Post-exposure Prophylaxis
... Hepatitis A virus (HAV) chapter within Appendix A provides post-exposure prophylaxis (PEP) recommendations under the section titled ‘Management of Contacts’.1 The PEP recommendations cite the 2006 Canadian Immunization Guide (CIG) which recommends to administer HAV vaccine to contacts, including con ...
... Hepatitis A virus (HAV) chapter within Appendix A provides post-exposure prophylaxis (PEP) recommendations under the section titled ‘Management of Contacts’.1 The PEP recommendations cite the 2006 Canadian Immunization Guide (CIG) which recommends to administer HAV vaccine to contacts, including con ...
Background Paper on Yellow Fever Vaccine
... detectable levels of serum neutralizing antibodies up to 20 years post vaccination (Table 1). Studies that have looked at persons 20 or more years after vaccination have found that approximately 80% of vaccine recipients still have detectable levels of neutralizing antibodies [12, 14, 15, 17]. One o ...
... detectable levels of serum neutralizing antibodies up to 20 years post vaccination (Table 1). Studies that have looked at persons 20 or more years after vaccination have found that approximately 80% of vaccine recipients still have detectable levels of neutralizing antibodies [12, 14, 15, 17]. One o ...
Global measles elimination - Measles and Rubella Initiative
... Abstract | Measles remains a leading vaccine-preventable cause of child mortality worldwide, particularly in sub-Saharan Africa where almost half of the estimated 454,000 measles deaths in 2004 occurred. However, great progress in measles control has been made in resourcepoor countries through accel ...
... Abstract | Measles remains a leading vaccine-preventable cause of child mortality worldwide, particularly in sub-Saharan Africa where almost half of the estimated 454,000 measles deaths in 2004 occurred. However, great progress in measles control has been made in resourcepoor countries through accel ...
Delivery strategies to enhance oral vaccination against
... the option of self-administration. In addition to reducing the need for highly trained medical personnel to administer vaccines, this also avoids the risks of disease transmission through contaminated equipment [20,21]. If the oral route is to be an applicable solution for largescale vaccination wit ...
... the option of self-administration. In addition to reducing the need for highly trained medical personnel to administer vaccines, this also avoids the risks of disease transmission through contaminated equipment [20,21]. If the oral route is to be an applicable solution for largescale vaccination wit ...
ç¦å³¶çç«å»ç§å¤§å¦ å¦è¡æ©é¢ãªãã¸ããª
... half of 1993, the number of mumps cases was low; however, nation-wide surveillance identified an incidence of approximately one case of post-vaccination aseptic meningitis per 1,000 (0.1%) persons receiving the MMR vaccination containing the Urabe mumps strain l l ), so the Japanese Ministry of Heal ...
... half of 1993, the number of mumps cases was low; however, nation-wide surveillance identified an incidence of approximately one case of post-vaccination aseptic meningitis per 1,000 (0.1%) persons receiving the MMR vaccination containing the Urabe mumps strain l l ), so the Japanese Ministry of Heal ...
Immunization Competencies for Health Professionals
... Directorate (BGTD) of Health Canada. Like all medicines, vaccines must undergo rigorous review and testing before they are approved for use. Health Canada also supervises all aspects of vaccine production by the manufacturers to ensure safety, sterility, and quality. Before a new vaccine can be subm ...
... Directorate (BGTD) of Health Canada. Like all medicines, vaccines must undergo rigorous review and testing before they are approved for use. Health Canada also supervises all aspects of vaccine production by the manufacturers to ensure safety, sterility, and quality. Before a new vaccine can be subm ...
Poster: MenBioVax generates cross strain immunogenicity
... America, no broadly effective vaccine has been approved. This is due in part to the low immunogenicity of the serogroup B capsular polysaccharide. ...
... America, no broadly effective vaccine has been approved. This is due in part to the low immunogenicity of the serogroup B capsular polysaccharide. ...
Chicken Pox Fact Sheet
... from vomiting or diarrhea, or more serious complications such as pneumonia and encephalitis. In vaccinated children, chickenpox illness is typically mild, producing no symptoms at all other than a few red bumps. However, about 25% to 30% of vaccinated children who get the disease will develop illnes ...
... from vomiting or diarrhea, or more serious complications such as pneumonia and encephalitis. In vaccinated children, chickenpox illness is typically mild, producing no symptoms at all other than a few red bumps. However, about 25% to 30% of vaccinated children who get the disease will develop illnes ...
View PDF - OMICS International
... tissue infection in injectional drug users is emerging due to unsanitary practices [11]. The deadliness of anthrax depends on the route of infection. Aerosolized endospores, targeting the inhalation route, are relatively easy to disseminate and were goals of bioweapons programs. Unfortunately, pulmo ...
... tissue infection in injectional drug users is emerging due to unsanitary practices [11]. The deadliness of anthrax depends on the route of infection. Aerosolized endospores, targeting the inhalation route, are relatively easy to disseminate and were goals of bioweapons programs. Unfortunately, pulmo ...
IMMUNOREGULATION OF HEPATITIS B VIRUS INFECTION
... Currently, the only available vaccine for HBV is the hepatitis B surface antigen (HBsAg) vaccine, which is usually used for the prophylaxis of HBV infection, as mentioned above. The HBsAg vaccine elicits a level of anti-hepatitis B surface antigen antibody (HBsAb) high enough to protect against the ...
... Currently, the only available vaccine for HBV is the hepatitis B surface antigen (HBsAg) vaccine, which is usually used for the prophylaxis of HBV infection, as mentioned above. The HBsAg vaccine elicits a level of anti-hepatitis B surface antigen antibody (HBsAb) high enough to protect against the ...
Exhibit N. a general information booklet on vaccine safety for parents titled VACCINE SAFETY AND YOUR CHILD, Separating Fact from Fiction , an excerpt from the book Vaccines and Your Child. (PDF: 2.20MB/34 pages)
... a result, children can suffer massive intestinal bleeding. Also, bacteria that normally live on the intestinal surface can enter the bloodstream, causing a serious infection. Either of these problems can be fatal. After RotaShield had been given for several months, fifteen cases of intussusception w ...
... a result, children can suffer massive intestinal bleeding. Also, bacteria that normally live on the intestinal surface can enter the bloodstream, causing a serious infection. Either of these problems can be fatal. After RotaShield had been given for several months, fifteen cases of intussusception w ...
Rhesus macaque and mouse models for down
... Full list of author information is available at the end of the article ...
... Full list of author information is available at the end of the article ...
Molecular detection and characterisation of mumps virus in
... of aseptic meningitis attributable to MuV varies depending on ...
... of aseptic meningitis attributable to MuV varies depending on ...
Chapter 1: Overview of Interface
... Once connection is verified then provider will upload all immunization data to the Registry thru a batch file (See page 20). 6. Once the legacy data is imported to the KSWebIZ training site KDHE will review this data in KSWebIZ to verify data quality. If any errors are identified then KDHE will work ...
... Once connection is verified then provider will upload all immunization data to the Registry thru a batch file (See page 20). 6. Once the legacy data is imported to the KSWebIZ training site KDHE will review this data in KSWebIZ to verify data quality. If any errors are identified then KDHE will work ...
Rotavirus: Questions and Answers
... A person may develop rotavirus disease more than once because there are many different rotavirus types, but second infections tend to be less severe than the first infections. After a single natural infection, 40% of children are protected against a subsequent rotavirus illness. Persons of all ages ...
... A person may develop rotavirus disease more than once because there are many different rotavirus types, but second infections tend to be less severe than the first infections. After a single natural infection, 40% of children are protected against a subsequent rotavirus illness. Persons of all ages ...
phase ii safety and immunogenicity study of live
... study of a serially passaged, plaque-purified live chikungunya (CHIK) vaccine in 73 healthy adult volunteers. Fiftynine volunteers were immunized one time subcutaneously with the CHIK vaccine and 14 were immunized with placebo (tissue culture fluid). Vaccinees were clinically evaluated intensively f ...
... study of a serially passaged, plaque-purified live chikungunya (CHIK) vaccine in 73 healthy adult volunteers. Fiftynine volunteers were immunized one time subcutaneously with the CHIK vaccine and 14 were immunized with placebo (tissue culture fluid). Vaccinees were clinically evaluated intensively f ...